HK1006148A1 - Use of a combination of an ace inhibitor with a calcium antagonist in the treatment of proteinuria - Google Patents

Use of a combination of an ace inhibitor with a calcium antagonist in the treatment of proteinuria Download PDF

Info

Publication number
HK1006148A1
HK1006148A1 HK98105249A HK98105249A HK1006148A1 HK 1006148 A1 HK1006148 A1 HK 1006148A1 HK 98105249 A HK98105249 A HK 98105249A HK 98105249 A HK98105249 A HK 98105249A HK 1006148 A1 HK1006148 A1 HK 1006148A1
Authority
HK
Hong Kong
Prior art keywords
alkyl
carbon atoms
aryl
atoms
optionally substituted
Prior art date
Application number
HK98105249A
Other languages
German (de)
English (en)
French (fr)
Chinese (zh)
Other versions
HK1006148B (en
Inventor
Becker Reinhard
Henning Rainer
Teetz Volker
Urbach Hansjorg
Original Assignee
Sanofi-Aventis Deutschland Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=6419005&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HK1006148(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Sanofi-Aventis Deutschland Gmbh filed Critical Sanofi-Aventis Deutschland Gmbh
Publication of HK1006148A1 publication Critical patent/HK1006148A1/xx
Publication of HK1006148B publication Critical patent/HK1006148B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55—Protease inhibitors
    • A61K38/556—Angiotensin converting enzyme inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
    • A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Vascular Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Endocrinology (AREA)
  • Urology & Nephrology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Rheumatology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Reproductive Health (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
HK98105249.1A 1990-11-27 1998-06-12 Use of a combination of an ace inhibitor with a calcium antagonist in the treatment of proteinuria HK1006148B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE4037691 1990-11-27
DE4037691 1990-11-27

Publications (2)

Publication Number Publication Date
HK1006148A1 true HK1006148A1 (en) 1999-02-12
HK1006148B HK1006148B (en) 1999-02-12

Family

ID=

Also Published As

Publication number Publication date
CA2055948A1 (en) 1992-05-28
CY2109B1 (en) 2002-04-26
DK0488059T3 (da) 1996-01-02
HUT62468A (en) 1993-05-28
EP0649654B1 (de) 1999-02-10
ES2079545T3 (es) 1996-01-16
ZA919318B (en) 1992-08-26
CZ286187B6 (cs) 2000-02-16
NO914637D0 (no) 1991-11-26
CZ286168B6 (cs) 2000-02-16
JPH04308533A (ja) 1992-10-30
IE914111A1 (en) 1992-06-03
NO311070B1 (no) 2001-10-08
KR100225997B1 (ko) 1999-10-15
YU180491A (sh) 1995-12-04
CN1060679C (zh) 2001-01-17
CA2055948C (en) 2002-11-12
EP0649654A1 (de) 1995-04-26
JP2608355B2 (ja) 1997-05-07
YU48978B (sh) 2003-02-28
ATE176592T1 (de) 1999-02-15
DK0649654T3 (da) 1999-09-20
IE68600B1 (en) 1996-06-26
CY2191B1 (en) 2002-11-08
EP0488059A2 (de) 1992-06-03
DE59109099D1 (de) 1999-03-25
CN1072601A (zh) 1993-06-02
AU655784B2 (en) 1995-01-12
HU913674D0 (en) 1992-02-28
EP0488059B1 (de) 1995-09-06
US5366994A (en) 1994-11-22
NO914637L (no) 1992-05-29
DE59106422D1 (de) 1995-10-12
EP0488059A3 (en) 1992-11-25
CS358791A3 (en) 1992-06-17
ES2129563T3 (es) 1999-06-16
SK279626B6 (sk) 1999-01-11
TW197945B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1993-01-11
US5236933A (en) 1993-08-17
ATE127346T1 (de) 1995-09-15
AU8811791A (en) 1992-05-28
GR3017588T3 (en) 1995-12-31
HU219447B (hu) 2001-04-28
GR3030022T3 (en) 1999-07-30
HK1011927A1 (en) 1999-07-23
KR920009392A (ko) 1992-06-25

Similar Documents

Publication Publication Date Title
US5098910A (en) Combination of angiotensin-converting enzyme inhibitors with calcium antagonists as well as their use in drugs
US5256687A (en) Pharmaceutical composition for the treatment of high blood pressure
AU594711B2 (en) A method for the treatment of atherosclerosis, thrombosis and peripheral vesseldisease
US5231083A (en) Method for the treatment of cardiac and of vascular hypertrophy and hyperplasia
US5236933A (en) Use of a combination of angiotensin-converting enzyme inhibitor and calcium antagonist for the treatment of proteinuria
US5231080A (en) Method for the treatment of atherosclerosis, thrombosis, and peripheral vessel disease
CA1332350C (en) Combination of angiotensin converting enzyme inhibitors with potassium channel modulators and use thereof in pharmaceuticals
US5684016A (en) Method of treating cardiac insufficiency
JPS60231696A (ja) 心機能不全症治療剤
HK1006148B (en) Use of a combination of an ace inhibitor with a calcium antagonist in the treatment of proteinuria
JPH01128997A (ja) アミノ酸エステル及びその製造方法
NO863583L (no) Farmasoeytisk tilberedning til behandling av hoeyt blodtrykk

Legal Events

Date Code Title Description
PF Patent in force
PE Patent expired

Effective date: 20111120